Portside Wealth Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Portside Wealth Group’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$465K	Buy	+23,086	New	+$416K	0.05%	322

Other funds holding AMRX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Signature Wealth Management Partners Montvale, New Jersey $234M AUM 23.06% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return

Campbell Newman Asset Management Milwaukee, Wisconsin $1.33B AUM 26.63% 1-Year Est. Return

Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Portside Wealth Group's AMRX Position: Q3 2026 in Review

Portside Wealth Group opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2026: 23,086 shares worth $465K. The stake represents 0.05% of the portfolio and ranks #322 among its holdings.

65 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

Portside Wealth Group held 23,086 shares of Amneal Pharmaceuticals worth $465K as of Q3 2026.
Amneal Pharmaceuticals was a new Portside Wealth Group position in Q3 2026.
Amneal Pharmaceuticals made up 0.05% of Portside Wealth Group's portfolio in Q3 2026, its #322 holding.
65 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Portside Wealth Group's 13F filing for Q3 2026, filed 20 Oct 2026.